Adagio Therapeutics changes name to Invivyd, generates COVID-19 antibodies

seekingalpha2022-09-12

Biopharmaceutical company Adagio Therapeutics (NASDAQ:ADGI) changed its name to Invivyd. The company will begin trading under the new ticker symbol IVVD on the Nasdaq Global Market from Sep. 13. The ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2266328506?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-12 19:59","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2266328506","market":"us","top_or_hot":-1,"title":"Adagio Therapeutics changes name to Invivyd, generates COVID-19 antibodies","media":"seekingalpha","content":"<div>\n<p>Biopharmaceutical company Adagio Therapeutics (NASDAQ:ADGI) changed its name to Invivyd.\nThe company will begin trading under the new ticker symbol IVVD on the Nasdaq Global Market from Sep. 13.\nThe ...</p>\n\n<a href=\"https://seekingalpha.com/news/3881928-adagio-therapeutics-changes-name-to-invivyd-generates-covid-19-antibodies\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adagio Therapeutics changes name to Invivyd, generates COVID-19 antibodies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdagio Therapeutics changes name to Invivyd, generates COVID-19 antibodies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-12 19:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3881928-adagio-therapeutics-changes-name-to-invivyd-generates-covid-19-antibodies><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biopharmaceutical company Adagio Therapeutics (NASDAQ:ADGI) changed its name to Invivyd.\nThe company will begin trading under the new ticker symbol IVVD on the Nasdaq Global Market from Sep. 13.\nThe ...</p>\n\n<a href=\"https://seekingalpha.com/news/3881928-adagio-therapeutics-changes-name-to-invivyd-generates-covid-19-antibodies\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美国抗疫概念","start_time":0,"source_url":"https://seekingalpha.com/news/3881928-adagio-therapeutics-changes-name-to-invivyd-generates-covid-19-antibodies","article_id":"2266328506","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2266328506","pubTimestamp":1662983969,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Biopharmaceutical company Adagio Therapeutics (NASDAQ:ADGI) changed its name to Invivyd.\nThe company","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4568":"美国抗疫概念","IVVD":"Invivyd, Inc.","BNTX":"BioNTech SE","BK4535":"淡马锡持仓","BK4551":"寇图资本持仓","BK4139":"生物科技","BK4548":"巴美列捷福持仓","BK4539":"次新股"},"translate_title":"慢板治疗公司更名为Invivyd，产生新冠肺炎抗体","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADGI":1,"BNTX":1,"IVVD":1},"content_text":"Biopharmaceutical company Adagio Therapeutics (NASDAQ:ADGI) changed its name to Invivyd.\nThe company will begin trading under the new ticker symbol IVVD on the Nasdaq Global Market from Sep. 13.\nThe new name considers the company's strategy associated with the development and commercialization of antibodies.\nThe company has also adopted a new logo and refreshed its corporate website.\nAdditionally, ADGI said it has generated multiple next-generation candidate antibodies for the prevention and treatment of COVID-19. The antibodies include two molecules designated for near-term clinical development in combination as NVD200.\nNVD200 is expected to enter the clinic in Q1 2023.\nShares were trading +6.09% pre-market.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2266328506"}